Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15212361 | 0.86 | CDC25A (0.37) | CDC25AHPGDALOX15 | |
| SCHEMBL28355508 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL17419072 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL5878763 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL4428238 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL13042277 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL4065812 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL4752338 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL92698 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD | |
| SCHEMBL17418564 | 0.86 | CDC25A (0.55) | CDC25AGNAI3GNAO1GNAI1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2279172-B1 | USE OF IONIC LIQUIDS WITH TETRACYANOBORATE ANIONS AS A SOLVENT FOR EXTRACTION OF ALCOHOLS FROM AQUEOUS SOLUTIONS | MERCK PATENT GMBH (DE) | 2013-06-26 | — | — | EP | claimed |
| US-8455703-B2 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | claimed |
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GESELLSCHAFT (DE) | 2011-03-24 | — | — | US | claimed |
| US-8455703-B2 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GESELLSCHAFT (DE) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | ADH1C, SLC6A6, ADH5 | CDC25A 4169/4885GNAI3 2024/4885GNAO1 2847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.